ARCHIVES

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

NCI to Spend 40 Percent of Stimulus Funds On Contracts

June 26, 2009

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

February 20, 1981

BMS Demands Resignation Of Two ImClone Executives

February 8, 2002

US Oncology Inc. Asked For Drug Purchase Information.

July 4, 2003

Richard Pazdur’s Comments to ODAC

July 22, 2011

Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib

June 27, 2014